March 22 is Lynch Syndrome Awareness Day. Lynch syndrome is one of only two common hereditary digestive cancer syndromes.

In order to get to know the disease better and to be able to support patients properly, […]

The Board of Digestive Cancers Europe,  with sincere regret, has received the resignation of its Chief Executive Officer Stefan Gijssels.During his tenure Digestive Cancers Europe has made many notable s […]

February 4, Acting CEO, Zorana Maravic took part in the European Liver Patients Association’s (ELPA) ‘Liver Cancer Patient Summit’. Here she spoke of DiCE’s continued commitment to our partnership with the […]

In 2019, EuropaColon Poland became the first recipient of the Wolfram Nolte Memorial Award – established by DiCE in memory of the former leader of the DiCE member organization in Germany. The Polish patient […]

On Monday 11 January 2021, a public hearing of the Special Committee on Beating Cancer took place at the European Parliament focusing on empowering patients and their caregivers.

Members of the European […]

Oesophageal cancer is a less common cancer type with two main forms, adenocarcinoma and squamous cell carcinoma. If surgery is not an option, the only treatments available in Europe so far has been radiotherapy, […]

The recent decision by the European Medicines Agency’s (EMA) to approve atezolizumab (Tecentriq®) in combination with bevacizumab for the treatment of patients with advanced unresectable hepatocellular ca […]

We are pleased to make available a series of brochures for people living with metastatic colorectal cancer (mCRC) and their team of healthcare professionals. The brochures better the patient experience in a […]

Digestive Cancers Europe is proud to announce that Wolfram Nolte Memorial Award for 2020 goes to Portugal for its project aiming to provide palliative support for mCRC patients and their loved ones.

EuropaColon […]

November is Gastric Cancer Awareness Month. Understand more about the disease and gain a patient perspective below.

About Gastric Cancer

Gastric cancer (GC), also known as stomach cancer, is a disease that […]

A study published in the journal Gut has shown that a simple and inexpensive blood test could distinguish patients with stomach or oesophageal cancer likely to benefit from targeted treatment. This is outlined in […]

For the first time Digestive Cancers Europe offered its Members a session on liver cancer. This was a part of our annual Masterclass Series with the event centred on patient advocate education, along with our […]

On 8 October 2020 DiCE invited European experts from the fields of oncology, nursing, pharmacology, patient advocacy, health economics and the industry to participate in an online workshop to identify and discuss […]

New study calculates total costs – lives can be saved, and money can be saved
For the first time ever, the total cost of all digestive cancers across Europe has been evaluated by type of digestive cancer, by type […]

It is with great pleasure that we welcome the Spanish patient organisation The Association Against Gastric Cancer and Gastrectomized Patients (ACCGG) to our family of Members.

The Association would like to […]

DiCE Director of Operations Zorana Maravic is the lead and first author of the study: ‘A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and […]

Digestive Cancers Europe (DiCE) and the European Liver Patients’ Association (ELPA) Start Official Partnership

Today, two European patient advocacy umbrella organisations, DiCE and ELPA, signed a Memorandum of […]

With DiCE patient input, our partner COR2ED, creator of high quality Independent Medical Education programmes has launched a new blended learning program for oncology nurses and advanced practice providers. This […]